- Home
- XXII vs TRIB Comparison
XXII vs TRIB Comparison
Compare XXII & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- TRIB
- Stock Information
- Founded
- XXII 1998
- TRIB 1992
- Country
- XXII United States
- TRIB Ireland
- Employees
- XXII N/A
- TRIB N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- XXII Health Care
- TRIB Health Care
- Exchange
- XXII Nasdaq
- TRIB Nasdaq
- Market Cap
- XXII 6.2M
- TRIB 5.4M
- IPO Year
- XXII N/A
- TRIB N/A
- Fundamental
- Price
- XXII $1.67
- TRIB $0.98
- Analyst Decision
- XXII
- TRIB
- Analyst Count
- XXII 0
- TRIB 0
- Target Price
- XXII N/A
- TRIB N/A
- AVG Volume (30 Days)
- XXII 341.7K
- TRIB 120.8K
- Earning Date
- XXII 11-04-2025
- TRIB 11-14-2025
- Dividend Yield
- XXII N/A
- TRIB N/A
- EPS Growth
- XXII N/A
- TRIB N/A
- EPS
- XXII N/A
- TRIB N/A
- Revenue
- XXII $21,362,000.00
- TRIB $61,555,000.00
- Revenue This Year
- XXII N/A
- TRIB $13.51
- Revenue Next Year
- XXII $126.57
- TRIB $13.14
- P/E Ratio
- XXII N/A
- TRIB N/A
- Revenue Growth
- XXII N/A
- TRIB 8.31
- 52 Week Low
- XXII $1.43
- TRIB $0.48
- 52 Week High
- XXII $394.02
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- XXII 52.22
- TRIB 43.05
- Support Level
- XXII $1.48
- TRIB $0.88
- Resistance Level
- XXII $1.62
- TRIB $1.10
- Average True Range (ATR)
- XXII 0.09
- TRIB 0.07
- MACD
- XXII 0.03
- TRIB 0.00
- Stochastic Oscillator
- XXII 65.57
- TRIB 42.19
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.